Telniz Beta 25 Tablet is prescribed primarily for managing high blood pressure, also known as hypertension, when unmanaged can lead to severe complications such as heart attacks and strokes. This medicine belongs to the category of antihypertensives, incorporating two pharmacologically active substances to achieve its therapeutic effect.
• Long-term management of hypertension
• Reducing cardiac strain by reducing heart rate
• Lowering the likelihood of cardiovascular events such as heart attacks and strokes
• Mitigating the risk of hypertension-related kidney complications
• Take this medicine as prescribed by your doctor.
• Aim to take it at a consistent time each day to maintain stable blood levels.
• Swallow the tablet whole; do not crush, chew, or break it.
• Adhere to your doctor’s instructions regarding dosage and duration, irrespective of your health status.
Telniz Beta 25 Tablet is taken orally.
Potential side effects associated with Telniz Beta 25 Tablet may include:
• Headache
• Weakness
• Dizziness
• Cold extremities
• Slow heart rate (bradycardia)
Telniz Beta 25 Tablet integrates two pharmacologically active components to exert its antihypertensive effects:
• Telmisartan (40 mg): As an angiotensin II receptor blocker (ARB), telmisartan counteracts the vasoconstrictive actions of angiotensin II, leading to vasodilation and subsequent blood pressure reduction.
• Metoprolol Succinate (25 mg): This beta-blocker diminishes the effects of catecholamines like epinephrine on the cardiovascular system, resulting in decreased heart rate and myocardial contractility.
Telniz Beta 25 Tablet is advised against use during pregnancy. Discontinue use and consult your doctor if pregnancy is detected.
Consult your doctor for advice on the potential risks and benefits before taking this medication while breastfeeding.
It is advisable to exercise caution with alcohol consumption, as it may potentiate the hypotensive effects of this medicine.
If you have pre-existing liver conditions, consult your doctor prior to initiating treatment with Telniz Beta 25 Tablet.
Inform your doctor if you have a history of renal issues before commencing this medication.
This medicine can cause dizziness or fatigue. Avoid driving or operating machinery if these effects are observed.
Notify your doctor if you have known allergies to any component of Telniz Beta 25 Tablet.
This medication is not recommended for individuals under 18 years of age.
Elderly patients should use this medication under strict medical supervision due to heightened sensitivity to side effects.
Drug-Drug Interactions
• Antihypertensives: May intensify the blood pressure-lowering effect.
• Potassium-increasing medications: May cause potential risk of hyperkalemia.
• NSAIDs: May reduce the antihypertensive efficacy of Telniz Beta 25 Tablet.
• Lithium: Possible augmentation of lithium toxicity.
Drug-Food Interactions
• Potassium-rich foods: Concurrent consumption may heighten blood potassium levels.
Drug-Disease Interactions
• Heart Conditions: Patients with severe heart block may experience adverse interactions.
Daily Dose
• Telniz Beta 25 Tablet should be taken as directed by your doctor. The dose is tailored to individual needs and response to treatment.
Missed Dose
• If you miss a dose, take it as soon as you remember. If it is close to the next dose, skip the missed dose and continue the regular schedule. Do not double the dose to make up for a missed one.
Overdose
• Symptoms of overdose may include dizziness, bradycardia, or weakness. Seek immediate medical attention if overdose is suspected.
• Store in a cool, dry place with temperatures not exceeding 30°C.
• Keep in original packaging to protect from moisture.
• Ensure it is out of reach of children.
• Use before the expiry date indicated on the packaging.
• Engage in regular physical activity like brisk walking or cycling to aid blood pressure management.
• Limit your dietary salt intake to support optimal blood pressure levels.
.avif)
%20(1).png)
.webp)